Delandistrogene Moxeparvovec for Duchenne Muscular Dystrophy

Delandistrogene moxeparvovec is a single-infusion gene therapy for the treatment of Duchenne muscular dystrophy.

If you have a Hayes login, click here to view the full report on the Knowledge Center.